RxDoctor Payments Data

Thad Waites, MD

Interventional Cardiology · Hattiesburg, MSNPI 1588773774

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,307 of the $3,125 with a category attached, or 73.8%. 18 manufacturers reported payments, led by Abbott at 35.8% of the total. 2025 is the largest year on record at $1,341, 3.2 times the $420 reported in 2019. That places this record below the midpoint for interventional cardiology clinicians in MS, where the typical reported total is $7,952.

$3,125in general payments, 2019–2025

Across 113 payments — averaging $27.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • Boston Scientific$554
  • Abiomed$455
  • Cardiva Medical, Inc.$217
  • Biosense Webster, Inc.$180
  • Medtronic$171
  • plus $429 from 12 others

What the payments were for

  • Travel & lodging$81826%
  • Food & beverage$2,30774%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,125 in reported general payments places this provider in the 10th percentile of 65 interventional cardiology providers in Mississippi.

See all interventional cardiology providers in Mississippi

Medicare billing

Part B allowed, 2024
$60,198
Medicare patients
286
Services billed
1,131

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate272$1,547

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Hattiesburg

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →